Shield Therapeutics plc

STX.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents£5,608£13,948£2,821£12,117
Short-Term Investments£0£0£0£0
Receivables£20,164£10,600£3,753£1,773
Inventory£4,520£3,203£1,457£1,635
Other Curr. Assets£0£3,512£2,063£1,733
Total Curr. Assets£30,293£31,263£10,094£17,258
Property Plant & Equip (Net)£298£673£197£304
Goodwill£0£0£0£0
Intangibles£14,507£16,863£11,783£26,851
Long-Term Investments£798£0£0£0
Tax Assets£0£0£0£0
Other NC Assets£0£0£0£0
Total NC Assets£15,603£17,536£11,980£27,155
Other Assets£0£0£0£0
Total Assets£45,896£48,799£22,074£44,413
Liabilities
Payables£18,515£4,049£1,735£4,200
Short-Term Debt£352£382£196£366
Tax Payable£0£96£224£49
Deferred Revenue£0£0£0£0
Other Curr. Liab.£7,181£6,247£8,484-£1,235
Total Curr. Liab.£26,048£10,774£10,639£3,380
LT Debt£20,899£20,031£6,008£0
Deferred Rev, NC£0£0£0£0
Deferred Tax Liab, NC£0£0£0£0
Other NC Liab.£0£0£0£0
Total NC Liab.£20,899£20,031£6,008£1,467
Other Liabilities£0£2,961£0-£1,467
Cap. Leases£196£409£107£210
Total Liabilities£46,947£26,487£16,647£3,380
Equity
Pref Stock£0£0£0£0
Common Stock£15,896£11,775£4,465£3,238
Retained Earnings-£172,954-£233,525-£131,239-£78,579
AOCI-£6,233-£6,630-£8,681£1,449
Other Equity£197,673£233,542£140,895£114,583
Total Equity-£1,052£11,792£5,427£40,691
Supplemental Information
Minority Interest£0£0£0£0
Total Liab. & Tot. Equity£45,896£38,280£22,074£44,413
Net Debt£15,643£6,465£3,383-£11,751
Shield Therapeutics plc (STX.L) Financial Statements & Key Stats | AlphaPilot